Gufic Biosciences makes active pharmaceutical ingredients for a variety of uses and markets them in the Americas, Australia and elsewhere in Asia. The company was founded in 1984 and is ...

Gufic Biosciences has reported a sales total income from operations of Rs 56.11 crore and a net profit of Rs 2.42 crore for the quarter ended Dec '15 Gufic Bio standalone Sep '15 sales at Rs 51.42 ...

29-May-24--0.1 Rs.0.1000 per share(10%)Final Dividend 29-May-23-21-Sep-23 0.1 Rs.0.1000 per share(10%)Final Dividend 04-Jun-21-09-Sep-21 0.1 Rs.0.1000 per share(10%)Final Dividend ...

Gufic Biosciences Q1 Results Live : Gufic Biosciences declared their Q1 results on 14 Aug, 2024. The company reported a revenue increase of 4% year-over-year (YoY) and a profit increase of 1.13% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Companys total revenue from operations stood at 69,062.08 lakhs in the financial year 2022-23, thereby showing a decline as compared to 77,915.56 lakhs in the previous financial year 2021-22.

Gufic Bio Standalone March 2021 Net Sales at Rs 131.93 crore, up 61.7% Y-o-Y Gufic Bio Standalone December 2020 Net Sales at Rs 144.41 crore, up 47.74% Y-o-Y Gufic Biosciences Limited is primarily ...

Gufic BioSciences Ltd share price was down by -0.66% from the previous closing price of ₹411.20. Who are peers of Gufic BioSciences Ltd? The peers of Gufic BioSciences Ltd are Sun ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...